Dabigatran Reversal With Idarucizumab and In-Hospital Mortality in Intracranial Hemorrhage: A Systematic Review of Real-Life Data From Case Reports and Case Series

Background: Intracranial hemorrhage is a severe and possibly fatal consequence of anticoagulation therapy. Idarucizumab is used in dabigatran-treated patients suffering from intracranial hemorrhage (ICH) to reverse the anticoagulant effect of dabigatran. Systematic review of real-life mortality in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Frol, Senta, Sagris, Dimitrios, Šabovič, Mišo, Ntaios, George, Oblak, Janja Pretnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653877/
https://www.ncbi.nlm.nih.gov/pubmed/34899558
http://dx.doi.org/10.3389/fneur.2021.727403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653877/
https://www.ncbi.nlm.nih.gov/pubmed/34899558
http://dx.doi.org/10.3389/fneur.2021.727403

Ejemplares similares